Xaira Therapeutics today announced the appointment of Ian McCaffery, Ph.D., as Senior Vice President, Translational Science and Early Clinical Development, and the promotions of Ci Chu, Ph.D., to ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
AI is rocketing ahead. It is the biggest industrial revolution of our age. AI adoption is growing, but still most are at ...
As the era of AI agents—systems that can reason and act autonomously—begins, the power consumption of data centers is ...
Every evolution in software development has reduced the friction between an idea and a deployable application. AI may remove ...
For years, the promise of AI in software engineering has delivered incremental gains. Most organizations have adopted an ...
An analytical report on how high-performing companies use productivity, talent, technology, and operating models to build ...
The Trump administration’s latest restrictions on private AI model releases is ramping up the push for open-source ...
Every investment decision starts with information. The quality of that information determines the quality of the decision. It really is that simple — and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results